The antimicrobial peptide pheromone Plantaricin A increases antioxidant defenses of human keratinocytes and modulates the expression of filaggrin, involucrin, β-defensin 2 and tumor necrosis factor-α genes

Experimental Dermatology

Volumn 21, Issue 9, 2012, Pages 665-671

  Marzani, Barbara ^a   Pinto, Daniela ^a,b   Minervini, Fabio ^b   Calasso, Maria ^b   Di Cagno, Raffaella ^b   Giuliani, Giammaria ^a   Gobbetti, Marco ^b   De Angelis, Maria ^b  

^a GIULIANI S P A   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Filaggrin; HBD 2; Human keratinocytes; Involucrin; Lactobacillus plantarum; Plantaricin A; TNF gene

Indexed keywords

ALPHA TOCOPHEROL; BETA DEFENSIN 2; FILAGGRIN; HYALURONIC ACID; INVOLUCRIN; PHEROMONE DERIVATIVE; PLANTARICIN A; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; SYNTHESIS; UPREGULATION;

ALPHA-TOCOPHEROL; ANALYSIS OF VARIANCE; BACTERIOCINS; BETA-DEFENSINS; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; INTERMEDIATE FILAMENT PROTEINS; KERATINOCYTES; LIPOPOLYSACCHARIDES; OXIDATIVE STRESS; PROTEIN PRECURSORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84865327155     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01538.x     Document Type: Article

References (68)

1. Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes S O et al. Clin Immunol 2010: 135: 1-11.
2. Fimland G, Johnsen L, Dalhus B et al. J Pept Sci 2005: 11: 688-696.
3. Chen H M, Leung K W, Thakur N et al. Eur J Biochem 2003: 270: 911-920.
4. Shai Y. Biopolymers 2002: 66: 236-248.
5. Mallbris L, Carlén L, Wei T et al. Exp Dermatol 2010: 19: 442-449.
6. Bulet P, Stöcklin R, Menin L. Immunol Rev 2004: 198: 169-184.
7. Schittek B, Paulmann M, Senyürek I et al. Infectious Disorders - Drug Targets 2008: 8: 135-143.
8. Kaus A, Jacobsen F, Sorkin M et al. Burns 2008: 34: 32-40.
9. Scott M G, Hancock R E. Crit Rev Immunol 2000: 20: 407-431.
10. Weinberg A, Krisanaprakornkit S, Dale B A. Crit Rev Oral Biol Med 1998: 9: 399-414.
11. Bardan A, Nizet V, Gallo R L. Expert Opin Biol Ther 2004: 4: 543-549.
12. de Pablo M A, Gaforio J J, Gallego A M et al. FEMS Immunol Med Microbiol 1999: 24: 35-42.
13. Begde D, Bundale S, Mashitha P et al. J Pept Sci 2011: 17: 438-444.
14. Diep D B, Havarstein L S, Nissen-Meyer J et al. Appl Environ Microbiol 1994: 60: 160-166.
15. Di Cagno R, De Angelis M, Calasso M et al. Proteomics 2010: 10: 2175-2190.
16. Diep D B, Havarstein L S, Nes I F. Mol Microbiol 1995: 18: 631-639.
17. Diep D B, Straume D, Kjos M et al. Peptides 2009: 30: 1562-1574.
18. Zhao H, Sood R, Jutila A et al. Biochim Biophys Acta 2006: 1758: 1461-1474.
19. Andersland K, Jølle G F, Sand O et al. J Membr Biol 2010: 235: 121-129.
20. Sand S L, Oppegård C, Ohara S et al. Peptides 2010: 31: 1237-1244.
21. Sand S L, Haug T M, Nissen-Meyer J et al. J Membr Biol 2007: 216: 61-71.
22. Pinto D, Marzani B, Minervini F et al. Peptides 2011: 32: 1815-1824.
23. Hughes D T, Sperandio V. Nat Rev Microbiol 2008: 6: 111-120.
24. FAO/WHO. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. FAO/WHO expert consultation report 2001.
25. Adams C A. Nutr Res Rev 2010: 23: 37-46.
26. Iannitti T, Palmieri B. Clin Nutr 2010: 29: 701-725.
27. van Hemert S, Moijerink M, Molenaar D et al. BMC Microbiol 2010: 10: 293.
28. Morini F, Dusatti F, Bonina F P et al. ATLA Altern Lab Anim 2000: 28: 427-433.
29. Calcabrini C, De Bellis R, Mancini U et al. Arch Dermatol Res 2010: 302: 191-200.
30. Kopfnagel V, Werfel T, Wittmann M. Exp Dermatol 2011: 20: 394-400.
31. Kline L, Sugihara T F. Appl Environ Microbiol 1971: 21: 459-465.
32. Gibbs P A, Patterson J T. J Appl Bacteriol 1980: 48: 191-205.
33. Eaves-Pyles T, Szabó C, Salzman A L. Infect Immun 1999: 67: 800-804.
34. Sanchez L, Mitjans M, Infante M R et al. Pharm Res 2004: 21: 1637-1641.
35. Hansen M B, Nielsen S E, Berg K. J Immunol Methods 1989: 119: 203-210.
36. Tobi S E, Paul N, McMillan T J. J Photochem Photobiol, B 2000: 57: 102-112.
37. Chomczynski P, Mackey K. Biotechniques 1995: 19: 942-945.
38. Vigetti D, Viola M, Karousou E et al. J Biol Chem 2008: 283: 4448-4458.
39. Neish A S. Gastroenterology 2009: 136: 65-80.
40. Turnbaugh P J, Hamady M, Yatsunenko T et al. Nature 2009: 457: 480-484.
41. Meijerink M, van Hemert S, Taverne N et al. PLoS ONE 2010: 5: e10632.
42. Halliwell B. Nutr Rev 1994: 52: 253-265.
43. Sarmadi B H, Ismail A. Peptides 2010: 31: 1949-1956.
44. Wells J M, Loonen L M, Karczewski J M. Int J Med Microbiol 2009: 300: 41-48.
45. Resta-Lenert S C, Barrett K E. Ann NY Acad Sci 2009: 1165: 175-182.
46. Resta-Lenert S, Barrett K E. Gut 2003: 52: 988-997.
47. Kalinin A, Marekov L N, Steinert P M. J Cell Sci 2001: 114: 3069-3070.
48. Candi E, Schmidt R, Melino G. Nat Rev Mol Cell Biol 2005: 6: 328-340.
49. Marekov L N, Steinert P M. J Biol Chem 1998: 273: 17763-17770.
50. Macheleidt O, Kaiser H W, Sandhoff K. J Invest Dermatol 2002: 119: 166-173.
51. Jensen J M, Fölster-Holst R, Baranowsky A et al. J Invest Dermatol 2004: 122: 1423-1431.
52. Noble W C Other cutaneous bacteria. In: Noble W C, ed. The Skin Microflora and Microbial Skin Disease. Cambridge: Cambridge University Press, 1992: 210-231.
53. Schröder J M, Harder J. Cell Mol Life Sci 2006: 63: 469-486.
54. Harder J, Bartels J, Christophers E et al. Nature 1997: 387: 861.
55. Kesting M R, Stoeckelhuber M, Hölzle F et al. Br J Dermatol 2010: 163: 121-127.
56. Diamond G, Russel J P, Bevins C L. Proc Natl Acad Sci U S A 1996: 797: 5156-5160.
57. Tarver A P, Clark D P, Diamond G et al. Infect Immun 1998: 66: 1045-1056.
58. Di Cagno R, Mazzacane F, Rizzello C G et al. Appl Microbiol Biotechnol 2010: 86: 731-741.
59. Schlee M, Harder J, Köten B et al. Clin Exp Immunol 2008: 151: 528-535.
60. Guaní-Guerra E, Negrete-García M C, Montes-Vizuet R et al. Arch Med Res 2011: 42: 189-194.
61. Kristensen M, Chu C Q, Eedy D J et al. Clin Exp Immunol 1993: 94: 354-362.
62. Ettehadi P, Greaves M W, Wallach D et al. Clin Exp Immunol 1994: 96: 146-151.
63. Richardson S K, Gelfand J M. Adv Dermatol 2008: 24: 171-196.
64. Kim B E, Howell M D, Guttman-Yassky E et al. J Invest Dermatol 2011: 131: 1272-1279.
65. Medina M, Izquierdo E, Ennahar S et al. Clin Exp Immunol 2007: 150: 531-538.
66. Foligne B, Nutten S, Grangette C et al. World J Gastroenterol 2007: 13: 236-243.
67. Miettinen M, Vuopio-Varkila J, Varkila K. Infect Immun 1996: 64: 5403-5405.
68. Peña J A, Versalovic J. Cell Microbiol 2003: 5: 277-285.